Related Experiment Video

Updated: Jul 7, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

New insights into mechanisms of statin-associated myotoxicity

Pascal Sirvent1, Jacques Mercier, Alain Lacampagne

  • 1INSERM, ER I25, F-34295 Montpellier, France.

Current Opinion in Pharmacology
|February 5, 2008
PubMed

Insights

Statins effectively treat high cholesterol but can cause muscle problems. Recent findings suggest mitochondrial and calcium disruptions are key mechanisms behind statin-induced myotoxicity.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Muscle Physiology

Background:

  • Statins are crucial for managing hypercholesterolemia and preventing atherosclerosis.
  • Despite benefits, statins frequently cause muscle-related side effects like myalgia and fatigue.
  • Understanding the mechanisms of statin myotoxicity is essential for patient care.

Purpose of the Study:

  • To review recent findings on the pathophysiological mechanisms of statin-induced myotoxicity.
  • To elucidate how statins impact muscle tissue at a molecular level.
  • To provide a comprehensive overview of current knowledge on statin myopathy.

Main Methods:

  • Review of recent scientific literature and research findings.
  • Analysis of proposed pathophysiological mechanisms for statin myotoxicity.
  • Integration of data on mitochondrial function, calcium cycling, and cellular processes.

Main Results:

  • Statin myotoxicity is multifactorial, involving cholesterol biosynthesis reduction and direct mitochondrial effects.
  • Mitochondrial impairment may lead to calcium leaks, disrupting sarcoplasmic reticulum calcium cycling.
  • These disruptions contribute to apoptosis, oxidative stress, muscle remodeling, and degeneration.

Conclusions:

  • Statin-induced myotoxicity involves complex interactions between mitochondrial dysfunction and calcium dysregulation.
  • These cellular impairments provide a basis for understanding the muscle symptoms experienced by patients.
  • Further research into these mechanisms could lead to improved statin therapies with reduced side effects.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...